Who Owns Capricor Therapeutics Stock?
NASDAQ: CAPRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 68.34%
- Held by insiders
- 9.44%
- Institutional holders
- 223
- Institutions 68.3%
- Insiders 9.4%
- Public and other 22.2%
Who owns Capricor Therapeutics stock?
Institutional investors own about 68.3% of Capricor Therapeutics's shares, spread across 223 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 9.44% of CAPR.
The largest institutional holders are Blackrock Inc. (7.19%), State Street Corporation (5.19%) and RA Capital Management, L.P. (5.18%). Together, the top 10 institutions control 36.9% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their CAPR positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CAPR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 4.18M | 7.19% | +0.8% |
| State Street Corporation | 3.02M | 5.19% | -11.1% |
| RA Capital Management, L.P. | 3.01M | 5.18% | +99.9% |
| Vanguard Capital Management LLC | 2.30M | 3.96% | +0.3% |
| Shaw D.E. & Co., Inc. | 2.14M | 3.68% | +1630.7% |
| Millennium Management Llc | 1.67M | 2.87% | +613.5% |
| UBS Group AG | 1.40M | 2.41% | +126.5% |
| EcoR1 Capital, LLC | 1.38M | 2.37% | +100.0% |
| Longaeva Partners L.P. | 1.23M | 2.12% | +1563.6% |
| Geode Capital Management, LLC | 1.14M | 1.96% | -17.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CAPR
| Fund | Shares | % Held |
|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.78M | 3.06% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.66M | 2.85% |
| iShares Trust-iShares Russell 2000 ETF | 1.41M | 2.42% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 597.34K | 1.03% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 591.51K | 1.02% |
| iShares Trust-iShares Russell 2000 Growth ETF | 500.25K | 0.86% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 308.38K | 0.53% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 248.91K | 0.43% |
| VANGUARD WORLD FUND-Vanguard Health Care Index Fund | 140.88K | 0.24% |
| SCHWAB CAPITAL TRUST-Schwab Small-Cap Index Fund | 130.63K | 0.22% |
Frequently asked questions
Who is the largest shareholder of Capricor Therapeutics?
Blackrock Inc. is the largest institutional shareholder of CAPR, owning 7.19% of shares outstanding (4.18M shares) as of its latest 13F filing.
What percentage of Capricor Therapeutics is owned by institutions?
Institutions own about 68.3% of CAPR shares and 75.5% of the public float.
How much of Capricor Therapeutics do insiders own?
Insiders, such as officers and directors, own about 9.44% of CAPR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.